Ottawa, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The global cell and gene therapy manufacturing market size was calculated at USD 21.15 billion in 2025 and is expected to reach around USD 215.18 billion by ...

As cell therapies scale, developers face a choice: redesign processes for all-in-one systems or manage complex bespoke ...

It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

eXmoor Pharma has received a Manufacturing and Import Authorisation for Investigational Medicinal Products (MIA(IMP)) license from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

Emily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be given a chimeric antigen receptor (CAR) T-cell therapy. After ...

Innovative solutions are making personalized cell and gene therapies accessible to all. Over the past two decades, 32 cell and gene therapies (CGTs) have been approved by the regulatory authorities ...

Automated cell therapy manufacturing pioneer Cellares has hit a key milestone, gaining a current Good Manufacturing Practice (cGMP) stamp of approval for its Cell Shuttle factory-in-a-box, which is ...

SAEL launches a 5GW solar manufacturing facility in Jewar, boosting India's renewable energy and creating thousands of jobs.

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

https://www.thehindubusinessline.com/companies/ola-may-incur-2200-crore-capex-in-fy25-for-cell-manufacturing-expansion/article68988345.ece Copy Ola Cell Technologies ...